Phase
Condition
Vomiting
Solid Tumors
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient has been diagnosed with histologically or cytologically confirmed solid cancer
Starting with first cycle of chemotherapy of moderate emetogenic risk, which does notinclude a combination of anthracycline plus cyclophosphamide
Age ≥ 18
WHO ≤ 1
Patient is able to understand and speak Dutch
Exclusion
Exclusion Criteria:
Patient with nausea and/or vomiting in 48 hours before start of chemotherapy treatment
Patient submitted to concomitant radiotherapy or submitted to radiotherapy 15 daysbefore start of chemotherapy or planned to receive radiotherapy during 8 days afteradministration of chemotherapy
Patient with concomitant severe comorbidy, such as: o Intestinal obstruction o Activepeptic ulcer o Hypercalcemia o Uncontrolled diabetes mellitus o Pheochromocytoma oTardive dyskinesia o Epilepsia o Active infective diseases o Brain - or leptomeningealmetastases o Psychiatrical disorders o Parkinsonism
Current use of corticosteroids (similar to prednisone ≥ 10 milligrams per day)
Current alcohol abuse
Pregnancy
Study Design
Connect with a study center
Gemini Ziekenhuis
Den Helder, Noord Holland 1782 GZ
NetherlandsSite Not Available
Tergooiziekenhuizen
Hilversum, Noord Holland 1213 XZ
NetherlandsSite Not Available
Medisch Centrum Alkmaar
Alkmaar, Noord-Holland 1815 JD
NetherlandsSite Not Available
Ziekenhuis Amstelland
Amstelveen, Noord-Holland 1186 AM
NetherlandsSite Not Available
Waterland Ziekenhuis
Purmerend, Noord-Holland 1441 RN
NetherlandsSite Not Available
De Heel - Zaans Medisch Centrum
Zaandam, Noord-Holland 1502 DV
NetherlandsSite Not Available
Rijnstate
Arnhem,
NetherlandsSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.